Literature DB >> 20031858

The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction.

Kim G Smolderen1, John A Spertus, Kimberly J Reid, Donna M Buchanan, Harlan M Krumholz, Johan Denollet, Viola Vaccarino, Paul S Chan.   

Abstract

BACKGROUND: Among patients with acute myocardial infarction (AMI), depression is both common and underrecognized. The association of different manifestations of depression, somatic and cognitive, with depression recognition and long-term prognosis is poorly understood. METHODS AND
RESULTS: Depression was confirmed in 481 AMI patients enrolled from 21 sites during their index hospitalization with a Patient Health Questionnaire (PHQ-9) score > or =10. Within the PHQ-9, separate somatic and cognitive symptom scores were derived, and the independent association between these domains and the clinical recognition of depression, as documented in the medical records, was evaluated. In a separate multisite AMI registry of 2347 patients, the association between somatic and cognitive depressive symptoms and 4-year all-cause mortality and 1-year all-cause rehospitalization was evaluated. Depression was clinically recognized in 29% (n=140) of patients. Cognitive depressive symptoms (relative risk per SD increase, 1.14; 95% CI, 1.03 to 1.26; P=0.01) were independently associated with depression recognition, whereas the association for somatic symptoms and recognition (relative risk, 1.04; 95% CI, 0.87 to 1.26; P=0.66) was not significant. However, unadjusted Cox regression analyses found that only somatic depressive symptoms were associated with 4-year mortality (hazard ratio [HR] per SD increase, 1.22; 95% CI, 1.08 to 1.39) or 1-year rehospitalization (HR, 1.22; 95% CI, 1.11 to 1.33), whereas cognitive manifestations were not (HR for mortality, 1.01; 95% CI, 0.89 to 1.14; HR for rehospitalization, 1.01; 95% CI, 0.93 to 1.11). After multivariable adjustment, the association between somatic symptoms and rehospitalization persisted (HR, 1.16; 95% CI, 1.06 to 1.27; P=0.01) but was attenuated for mortality (HR, 1.07; 95% CI, 0.94 to 1.21; P=0.30).
CONCLUSIONS: Depression after AMI was recognized in fewer than 1 in 3 patients. Although cognitive symptoms were associated with recognition of depression, somatic symptoms were associated with long-term outcomes. Comprehensive screening and treatment of both somatic and cognitive symptoms may be necessary to optimize depression recognition and treatment in AMI patients.

Entities:  

Mesh:

Year:  2009        PMID: 20031858      PMCID: PMC2779543          DOI: 10.1161/CIRCOUTCOMES.109.868588

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  38 in total

1.  Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis.

Authors:  Peter de Jonge; Johan Ormel; Rob H S van den Brink; Joost P van Melle; Titia A Spijkerman; Astrid Kuijper; Dirk J van Veldhuisen; Maarten P van den Berg; Adriaan Honig; Harry J G M Crijns; Aart H Schene
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

3.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Authors:  François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

4.  The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)--evaluating the impact of myocardial infarction on patient outcomes.

Authors:  John A Spertus; Eric Peterson; John S Rumsfeld; Philip G Jones; Carole Decker; Harlan Krumholz
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

5.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

6.  The importance of somatic symptoms in depression in primary care.

Authors:  André Tylee; Paul Gandhi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

7.  Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease.

Authors:  Claudia Walther; Sven Möbius-Winkler; Axel Linke; Mathias Bruegel; Joachim Thiery; Gerhard Schuler; Rainer Halbrecht
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2008-02

8.  Depressive symptoms and metabolic syndrome: is inflammation the underlying link?

Authors:  Lucile Capuron; Shaoyong Su; Andrew H Miller; J Douglas Bremner; Jack Goldberg; Gerald J Vogt; Carisa Maisano; Linda Jones; Nancy V Murrah; Viola Vaccarino
Journal:  Biol Psychiatry       Date:  2008-07-02       Impact factor: 13.382

9.  Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and health status in chronic heart failure.

Authors:  Angélique A Schiffer; Aline J Pelle; Otto R F Smith; Jos W Widdershoven; Eric H Hendriks; Susanne S Pedersen
Journal:  J Clin Psychiatry       Date:  2009-07-28       Impact factor: 4.384

10.  Recognition and treatment of depression in primary care: effect of patients' presentation and frequency of consultation.

Authors:  Marco Menchetti; Martino Belvederi Murri; Klea Bertakis; Biancamaria Bortolotti; Domenico Berardi
Journal:  J Psychosom Res       Date:  2008-12-16       Impact factor: 3.006

View more
  54 in total

Review 1.  Is there a high-risk subtype of depression in patients with coronary heart disease?

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

2.  Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial.

Authors:  William Whang; Matthew M Burg; Robert M Carney; Kenneth E Freedland; J Thomas Bigger; Diane Catellier; Susan Czajkowski; Nancy Frasure-Smith; Donald C Haas; Allan S Jaffe; Francois Lespérance; Vivian Medina; Joan Duer-Hefele; Gabrielle A Osorio; Faith Parsons; Peter A Shapiro; David S Sheps; Viola Vaccarino; Karina W Davidson
Journal:  Contemp Clin Trials       Date:  2012-05-25       Impact factor: 2.226

Review 3.  Depression in people with coronary heart disease: prognostic significance and mechanisms.

Authors:  Chris Dickens
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

4.  Depressive symptoms in patients with obstructive sleep apnea: biological mechanistic pathways.

Authors:  Diana A Chirinos; Indira Gurubhagavatula; Preston Broderick; Julio A Chirinos; Karen Teff; Thomas Wadden; Greg Maislin; Hassam Saif; Jesse Chittams; Caitlin Cassidy; Alexandra L Hanlon; Allan I Pack
Journal:  J Behav Med       Date:  2017-06-21

5.  Depression and rehospitalization following acute myocardial infarction.

Authors:  Rebecca L Reese; Kenneth E Freedland; Brian C Steinmeyer; Michael W Rich; Justin W Rackley; Robert M Carney
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-10-18

6.  Association between depression and inflammation--differences by race and sex: the META-Health study.

Authors:  Alanna Amyre Morris; Liping Zhao; Yusuf Ahmed; Neli Stoyanova; Christine De Staercke; William Craig Hooper; Gary Gibbons; Rebecca Din-Dzietham; Arshed Quyyumi; Viola Vaccarino
Journal:  Psychosom Med       Date:  2011-06-28       Impact factor: 4.312

7.  Leptin and its association with somatic depressive symptoms in patients with the metabolic syndrome.

Authors:  Diana A Chirinos; Ronald Goldberg; Marc Gellman; Armando J Mendez; Miriam Gutt; Judith R McCalla; Maria M Llabre; Neil Schneiderman
Journal:  Ann Behav Med       Date:  2013-08

8.  Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016.

Authors:  Jay S Patel; Youngha Oh; Kevin L Rand; Wei Wu; Melissa A Cyders; Kurt Kroenke; Jesse C Stewart
Journal:  Depress Anxiety       Date:  2019-07-29       Impact factor: 6.505

9.  Autonomic dysregulation in burnout and depression: evidence for the central role of exhaustion.

Authors:  Magdalena K Kanthak; Tobias Stalder; LaBarron K Hill; Julian F Thayer; Marlene Penz; Clemens Kirschbaum
Journal:  Scand J Work Environ Health       Date:  2017-05-18       Impact factor: 5.024

10.  Changes in cognitive versus somatic symptoms of depression and event-free survival following acute myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study.

Authors:  Annelieke M Roest; Robert M Carney; Kenneth E Freedland; Elisabeth J Martens; Johan Denollet; Peter de Jonge
Journal:  J Affect Disord       Date:  2013-03-11       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.